Patents by Inventor Hyunjeong OH

Hyunjeong OH has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Ergostenol glycoside derivative
    Patent number: 11059852
    Abstract: The present invention provides ergostenol glycoside derivatives, method for preventing, treating, or alleviating dermatitis using the same. The present invention also provides a method for preparing the ergostenol and glycoside derivatives thereof. The ergostenol and the glycoside derivatives thereof according to the present invention suppress the production of chemokines increasing according to the skin inflammation stimulation and inhibit the activity of transcriptional factors controlling the expression of various inflammation mediators in the prevention and treatment of dermatitis.
    Type: Grant
    Filed: July 22, 2019
    Date of Patent: July 13, 2021
    Assignee: ST PHARM CO., LTD.
    Inventors: Hakwon Kim, Tae Hoon Lee, Hoongyu Park, Hyunjeong Oh
  • NOVEL ERGOSTENOL GLYCOSIDE DERIVATIVE
    Publication number: 20190337976
    Abstract: The present invention provides ergostenol glycoside derivatives, method for preventing, treating, or alleviating dermatitis using the same. The present invention also provides a method for preparing the ergostenol and glycoside derivatives thereof. The ergostenol and the glycoside derivatives thereof according to the present invention suppress the production of chemokines increasing according to the skin inflammation stimulation and inhibit the activity of transcriptional factors controlling the expression of various inflammation mediators in the prevention and treatment of dermatitis.
    Type: Application
    Filed: July 22, 2019
    Publication date: November 7, 2019
    Applicant: ST PHARM CO., LTD.
    Inventors: Hakwon KIM, Tae Hoon LEE, Hoongyu PARK, Hyunjeong OH